Merck & Company Inc (MRK)vsTeleflex Incorporated (TFX)
MRK
Merck & Company Inc
$146.35
+3.83%
HEALTHCARE · Cap: $360.08B
TFX
Teleflex Incorporated
$138.98
-0.01%
HEALTHCARE · Cap: $5.53B
Smart Verdict
WallStSmart Research — data-driven comparison
Merck & Company Inc generates 2853% more annual revenue ($66.57B vs $2.25B). MRK leads profitability with a 4.8% profit margin vs -45.8%. TFX appears more attractively valued with a PEG of 0.16. TFX earns a higher WallStSmart Score of 52/100 (C-).
MRK
Hold36
out of 100
Grade: F
TFX
Buy52
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
-73.7%
Fair Value
$83.64
Current Price
$146.35
$62.71 premium
Margin of Safety
+9.1%
Fair Value
$117.70
Current Price
$138.98
$21.28 discount
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Mega-cap, among the largest globally
Generating 4.5B in free cash flow
Growing faster than its price suggests
Reasonable price relative to book value
Revenue surging 28.9% year-over-year
Areas to Watch
Trading at 8.6x book value
ROE of 7.6% — below average capital efficiency
4.8% margin — thin
Elevated debt levels
Distress zone — elevated risk
ROE of -32.7% — below average capital efficiency
Earnings declined 17.3%
Currently unprofitable
Comparative Analysis Report
WallStSmart ResearchBull Case : MRK
The strongest argument for MRK centers on Market Cap, Free Cash Flow.
Bull Case : TFX
The strongest argument for TFX centers on PEG Ratio, Price/Book, Revenue Growth. Revenue growth of 28.9% demonstrates continued momentum. PEG of 0.16 suggests the stock is reasonably priced for its growth.
Bear Case : MRK
The primary concerns for MRK are Price/Book, Return on Equity, Profit Margin. A P/E of 115.8x leaves little room for execution misses. Thin 4.8% margins leave little buffer for downturns.
Bear Case : TFX
The primary concerns for TFX are Altman Z-Score, Return on Equity, EPS Growth.
Key Dynamics to Monitor
MRK profiles as a value stock while TFX is a growth play — different risk/reward profiles.
TFX carries more volatility with a beta of 0.83 — expect wider price swings.
TFX is growing revenue faster at 28.9% — sustainability is the question.
MRK generates stronger free cash flow (4.5B), providing more financial flexibility.
Bottom Line
TFX scores higher overall (52/100 vs 36/100) and 28.9% revenue growth. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Merck & Company Inc
HEALTHCARE · DRUG MANUFACTURERS - GENERAL · USA
Merck & Co. is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668.
Visit Website →Teleflex Incorporated
HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES · USA
Teleflex Incorporated, headquartered in Wayne, Pennsylvania, is an American provider of specialty medical devices for a range of procedures in critical care and surgery.
Compare with Other DRUG MANUFACTURERS - GENERAL Stocks
Want to dig deeper into these stocks?